BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1916 related articles for article (PubMed ID: 33307546)

  • 1. Genetic mechanisms of critical illness in COVID-19.
    Pairo-Castineira E; Clohisey S; Klaric L; Bretherick AD; Rawlik K; Pasko D; Walker S; Parkinson N; Fourman MH; Russell CD; Furniss J; Richmond A; Gountouna E; Wrobel N; Harrison D; Wang B; Wu Y; Meynert A; Griffiths F; Oosthuyzen W; Kousathanas A; Moutsianas L; Yang Z; Zhai R; Zheng C; Grimes G; Beale R; Millar J; Shih B; Keating S; Zechner M; Haley C; Porteous DJ; Hayward C; Yang J; Knight J; Summers C; Shankar-Hari M; Klenerman P; Turtle L; Ho A; Moore SC; Hinds C; Horby P; Nichol A; Maslove D; Ling L; McAuley D; Montgomery H; Walsh T; Pereira AC; Renieri A; ; ; ; ; ; ; Shen X; Ponting CP; Fawkes A; Tenesa A; Caulfield M; Scott R; Rowan K; Murphy L; Openshaw PJM; Semple MG; Law A; Vitart V; Wilson JF; Baillie JK
    Nature; 2021 Mar; 591(7848):92-98. PubMed ID: 33307546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling identifies novel proteins for genetic risk of severe COVID-19: the Atherosclerosis Risk in Communities Study.
    Steffen BT; Pankow JS; Lutsey PL; Demmer RT; Misialek JR; Guan W; Cowan LT; Coresh J; Norby FL; Tang W
    Hum Mol Genet; 2022 Jul; 31(14):2452-2461. PubMed ID: 35212764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in
    Dieter C; de Almeida Brondani L; Lemos NE; Schaeffer AF; Zanotto C; Ramos DT; Girardi E; Pellenz FM; Camargo JL; Moresco KS; da Silva LL; Aubin MR; de Oliveira MS; Rech TH; Canani LH; Gerchman F; Leitão CB; Crispim D
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on human genetic susceptibility to COVID-19: susceptibility to virus and response.
    Colona VL; Vasiliou V; Watt J; Novelli G; Reichardt JKV
    Hum Genomics; 2021 Aug; 15(1):57. PubMed ID: 34429158
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-genome sequencing reveals host factors underlying critical COVID-19.
    Kousathanas A; Pairo-Castineira E; Rawlik K; Stuckey A; Odhams CA; Walker S; Russell CD; Malinauskas T; Wu Y; Millar J; Shen X; Elliott KS; Griffiths F; Oosthuyzen W; Morrice K; Keating S; Wang B; Rhodes D; Klaric L; Zechner M; Parkinson N; Siddiq A; Goddard P; Donovan S; Maslove D; Nichol A; Semple MG; Zainy T; Maleady-Crowe F; Todd L; Salehi S; Knight J; Elgar G; Chan G; Arumugam P; Patch C; Rendon A; Bentley D; Kingsley C; Kosmicki JA; Horowitz JE; Baras A; Abecasis GR; Ferreira MAR; Justice A; Mirshahi T; Oetjens M; Rader DJ; Ritchie MD; Verma A; Fowler TA; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Elliott P; Walsh T; Tenesa A; ; ; ; Fawkes A; Murphy L; Rowan K; Ponting CP; Vitart V; Wilson JF; Yang J; Bretherick AD; Scott RH; Hendry SC; Moutsianas L; Law A; Caulfield MJ; Baillie JK
    Nature; 2022 Jul; 607(7917):97-103. PubMed ID: 35255492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
    Gaziano L; Giambartolomei C; Pereira AC; Gaulton A; Posner DC; Swanson SA; Ho YL; Iyengar SK; Kosik NM; Vujkovic M; Gagnon DR; Bento AP; Barrio-Hernandez I; Rönnblom L; Hagberg N; Lundtoft C; Langenberg C; Pietzner M; Valentine D; Gustincich S; Tartaglia GG; Allara E; Surendran P; Burgess S; Zhao JH; Peters JE; Prins BP; Angelantonio ED; Devineni P; Shi Y; Lynch KE; DuVall SL; Garcon H; Thomann LO; Zhou JJ; Gorman BR; Huffman JE; O'Donnell CJ; Tsao PS; Beckham JC; Pyarajan S; Muralidhar S; Huang GD; Ramoni R; Beltrao P; Danesh J; Hung AM; Chang KM; Sun YV; Joseph J; Leach AR; Edwards TL; Cho K; Gaziano JM; Butterworth AS; Casas JP;
    Nat Med; 2021 Apr; 27(4):668-676. PubMed ID: 33837377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.
    Kakuta S; Shibata S; Iwakura Y
    J Interferon Cytokine Res; 2002 Sep; 22(9):981-93. PubMed ID: 12396720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort.
    Skerenova M; Cibulka M; Dankova Z; Holubekova V; Kolkova Z; Lucansky V; Dvorska D; Kapinova A; Krivosova M; Petras M; Baranovicova E; Baranova I; Novakova E; Liptak P; Banovcin P; Bobcakova A; Rosolanka R; Janickova M; Stanclova A; Gaspar L; Caprnda M; Prosecky R; Labudova M; Gabbasov Z; Rodrigo L; Kruzliak P; Lasabova Z; Matakova T; Halasova E
    Adv Med Sci; 2024 Mar; 69(1):198-207. PubMed ID: 38555007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
    Ma Y; Huang Y; Zhao S; Yao Y; Zhang Y; Qu J; Wu N; Su J
    Hum Mol Genet; 2021 Jun; 30(13):1247-1258. PubMed ID: 33949668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Found: genes that sway the course of the coronavirus.
    Kaiser J
    Science; 2020 Oct; 370(6514):275-276. PubMed ID: 33060342
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of IFNAR2 and TYK2 transcripts' prognostic role in COVID-19 patients: a retrospective study.
    Razavi A; Raei M; Hatami Y; Chokami GS; Goudarzi Y; Ghasemian R; Alizadeh-Navaei R; Yarmohammadi H; Soltanipur M; Tabarestani M; Valadan R; Meshkinfam Haghighi F; Tarsi AK; Razavi B
    Front Cell Infect Microbiol; 2024; 14():1356542. PubMed ID: 38741892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
    Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the correlation between
    Safari M; Tavakoli R; Aghasadeghi M; Tabatabaee Bafroee AS; Fateh A; Rahimi P
    Nucleosides Nucleotides Nucleic Acids; 2024 Apr; ():1-16. PubMed ID: 38660988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
    Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
    Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender.
    Sharif-Zak M; Abbasi-Jorjandi M; Asadikaram G; Ghoreshi ZA; Rezazadeh-Jabalbarzi M; Afsharipur A; Rashidinejad H; Khajepour F; Jafarzadeh A; Arefinia N; Kheyrkhah A; Abolhassani M
    Immunobiology; 2022 Mar; 227(2):152184. PubMed ID: 35131543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms.
    Hovnanian A; Rebouillat D; Mattei MG; Levy ER; Marié I; Monaco AP; Hovanessian AG
    Genomics; 1998 Sep; 52(3):267-77. PubMed ID: 9790745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1.
    Fink-Baldauf IM; Stuart WD; Brewington JJ; Guo M; Maeda Y
    EBioMedicine; 2022 Jan; 75():103806. PubMed ID: 34998241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
    Pairo-Castineira E; Rawlik K; Bretherick AD; Qi T; Wu Y; Nassiri I; McConkey GA; Zechner M; Klaric L; Griffiths F; Oosthuyzen W; Kousathanas A; Richmond A; Millar J; Russell CD; Malinauskas T; Thwaites R; Morrice K; Keating S; Maslove D; Nichol A; Semple MG; Knight J; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Begg C; Walsh T; Tenesa A; Flores C; Riancho JA; Rojas-Martinez A; Lapunzina P; ; ; ; ; Yang J; Ponting CP; Wilson JF; Vitart V; Abedalthagafi M; Luchessi AD; Parra EJ; Cruz R; Carracedo A; Fawkes A; Murphy L; Rowan K; Pereira AC; Law A; Fairfax B; Hendry SC; Baillie JK
    Nature; 2023 May; 617(7962):764-768. PubMed ID: 37198478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.
    Sava GP; Speedy HE; Di Bernardo MC; Dyer MJ; Holroyd A; Sunter NJ; Marr H; Mansouri L; Deaglio S; Karabon L; Frydecka I; Jamroziak K; Woszczyk D; Juliusson G; Smedby KE; Jayne S; Majid A; Wang Y; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
    Leukemia; 2015 Mar; 29(3):748-51. PubMed ID: 25363670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 96.